Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood
- PMID: 24361057
- DOI: 10.5414/CN108044
Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood
Abstract
Background: The aim of the study was to assess idiopathic nephrotic syndrome (INS) relapse rate, co-morbidities, and social status of adults diagnosed with INS in childhood.
Material and methods: A written questionnaire was sent to 118 adults treated for INS in childhood. In 61 (51.7%) responders (aged 26.0 ± 6.2 years, range 18 - 51.5 years), we used available medical records to evaluate age at the onset of INS, number of INS relapses below 18 years of age, response to corticosteroids (CS), renal biopsy findings, and immunosuppressive treatment as well as questionnaire to evaluate the number and treatment of INS relapses above 18 years of age, co-morbidities, age at menarche, marital status, offspring, educational status, and occupation.
Results: In the group of 61 responders, median age at the onset of INS was 3 (range 1.3 - 14.0) years, median number of INS relapses at < 18 years of age was 5 (1 - 20). Steroid-sensitive nephrotic syndrome (SSNS) was diagnosed in 37 (60.7%) patients, steroid-dependent nephrotic syndrome SDNS in 18 (29.5%) patients, and steroid-resistant nephrotic syndrome (SRNS) in 6 (9.8%) patients. Mesangial proliferation was the most common pattern in renal biopsy (35.7%). All patients received CS, 15 were treated with methylprednisolone pulses, 13 with cyclophosphamide, 11 with chlorambucil, 2 with cyclosporine, and 21 with levamisole. All patients achieved remission and had normal renal function at the age of 18. In adulthood, INS relapsed in 10 (16.4%) patients, including 5 (13.5%) patients with SSNS, 4 (22.2%) with SDNS, and 1 (16.7%) with SRNS (p = 0.72). Median number of relapses was 2 (range 1 - 11). Patients with relapses at > 18 years of age had more (p < 0.005) relapses at < 18 years of age. Hypertension was diagnosed in 8 (16.1%), overweight in 14 (23.0%), obesity in 3 (4.9%), and bone fractures in 12 (19.7%) patients. Five patients had height < 3rd percentile, including 4 with INS onset at < 3 years of age. One patient had growth retardation before the treatment. No myocardial infarctions, strokes, severe infections, or malignancies were reported. Mean age at menarche was 12.9 ± 1.4 years, 37 (60.7%) patients were in a steady relationship/ married, 1/18 (5.6%) patients treated with cytostatic agents and 12/43 (24/7%) patients not treated with cytostatic agents had offspring (p < 0.05). Elementary education was reported by 4 (6.6%), secondary education by 32 (52.5%), and higher education by 25 (40.9%) patients, and 34 (55.7%) patients were professionally active. None of the 6 patients with SRNS developed end-stage renal disease.
Conclusions: 1. High number of INS relapses in childhood is a risk factor for recurrences in adulthood. 2. INS relapses in childhood do not preclude active professional life in adulthood.
Similar articles
-
[Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].Zhonghua Er Ke Za Zhi. 2014 Mar;52(3):194-200. Zhonghua Er Ke Za Zhi. 2014. PMID: 24824389 Chinese.
-
Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome.Nephrol Dial Transplant. 2004 May;19(5):1136-41. doi: 10.1093/ndt/gfh066. Epub 2004 Feb 19. Nephrol Dial Transplant. 2004. PMID: 14993510
-
Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.Nephrol Dial Transplant. 2005 Nov;20(11):2433-8. doi: 10.1093/ndt/gfi059. Epub 2005 Oct 4. Nephrol Dial Transplant. 2005. PMID: 16204303
-
[Nephrotic syndrome in childhood].Orv Hetil. 2006 Nov 26;147(47):2251-60. Orv Hetil. 2006. PMID: 17380687 Review. Hungarian.
-
Rituximab for nephrotic syndrome in children.Clin Exp Nephrol. 2017 Apr;21(2):193-202. doi: 10.1007/s10157-016-1313-5. Epub 2016 Jul 15. Clin Exp Nephrol. 2017. PMID: 27422620 Free PMC article. Review.
Cited by
-
Impact of childhood nephrotic syndrome on obesity and growth: a prospective cohort study.Pediatr Nephrol. 2024 Apr 18. doi: 10.1007/s00467-024-06370-0. Online ahead of print. Pediatr Nephrol. 2024. PMID: 38637343
-
Repeated implants failure in young patient with idiopathic nephrotic syndrome: a case report with brief review of the literature.BMC Oral Health. 2024 Jan 5;24(1):25. doi: 10.1186/s12903-023-03772-8. BMC Oral Health. 2024. PMID: 38183071 Free PMC article. Review.
-
Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndrome.Nat Commun. 2023 Apr 29;14(1):2481. doi: 10.1038/s41467-023-37985-w. Nat Commun. 2023. PMID: 37120605 Free PMC article.
-
Change in Growth Status and Obesity Rates among Saudi Children and Adolescents Is Partially Attributed to Discrepancies in Definitions Used: A Review of Anthropometric Measurements.Healthcare (Basel). 2023 Apr 1;11(7):1010. doi: 10.3390/healthcare11071010. Healthcare (Basel). 2023. PMID: 37046938 Free PMC article. Review.
-
Assessment of Brain-Derived Neurotrophic Factor (BDNF) Concentration in Children with Idiopathic Nephrotic Syndrome.Int J Mol Sci. 2022 Oct 14;23(20):12312. doi: 10.3390/ijms232012312. Int J Mol Sci. 2022. PMID: 36293164 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical